Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Burkitt Lymphoma × Clear all

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT05651191 2022-12-14

To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT05480501 2022-07-29

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

NCT04626726 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT04191941 2019-12-10

Treatment of Hematological Malignancy With Novel CAR-T Cells.

Phase EARLY_PHASE1 Unknown

LymphoidPlasma cell

Burkitt Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT04184414 2019-12-03

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell